Calreticulin exposure increases cancer immunogenicity

Nature Biotechnology

Volumn 25, Issue 2, 2007, Pages 192-193

  Clarke, Chris ^a   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGY; MOLECULAR BIOLOGY; ONCOLOGY; TUMORS;

APOPTOSIS; CYTOTOXIC ANTICANCER DRUGS; IMMUNOGENIC; MOLECULAR SIGNAL;

DRUG PRODUCTS;

ANTHRACYCLINE; CALRETICULIN; CYTOKINE; DNA FRAGMENT; ETOPOSIDE; MITOMYCIN C; SMALL INTERFERING RNA; TAUTOMYCIN; TUMOR ANTIGEN;

APOPTOSIS; CANCER THERAPY; CELLULAR IMMUNITY; COLON CANCER; COMBINATION CHEMOTHERAPY; DRUG MECHANISM; DRUG RECEPTOR BINDING; IMMUNE RESPONSE; IMMUNOGENICITY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; TUMOR IMMUNITY;

ANIMALS; ANTHRACYCLINES; ANTIGENS, DIFFERENTIATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALRETICULIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; COLONIC NEOPLASMS; DENDRITIC CELLS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ETOPOSIDE; IMMUNOBLOTTING; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOMYCIN; NEOPLASMS, EXPERIMENTAL; PHAGOCYTOSIS; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; RNA INTERFERENCE;

EID: 33846882318     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0207-192     Document Type: Short Survey

References (8)

1. Casares, N. et al. J. Exp. Med. 202, 1691-1701 (2005).
2. Obeid, M. et al. Nat. Med. 13, 52-59 (2006).
3. Zong, W.X. & Thompson, C.B. Genes Dev. 20, 1-15 (2006).
4. Krysko, D.V., D'Herde, K. & Vandenabeele, P. Apoptosis 11, 1709-1726 (2006).
5. Henson, P.M., Bratton, D.L. & Fadok, V.A. Nat. Rev. Mol. Cell Biol. 2, 627-633 (2001).
6. Drake, C.G., Jaffee, E. & Pardoll, D.M. Adv. Immunol. 90, 51-81 (2006).
7. Davis, I.D., Jefford, M., Parente, P. & Cebon, J. J. Leukoc. Biol. 73, 3-29 (2003).
8. Lake, R.A. & van der Most, R.G. N. Engl. J. Med. 354, 2503-2504 (2006).